Federated Hermes’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.69K | Hold |
634
| – | – | ﹤0.01% | 1966 |
|
2025
Q1 | $5.09K | Buy |
634
+59
| +10% | +$474 | ﹤0.01% | 1873 |
|
2024
Q4 | $5.55K | Hold |
575
| – | – | ﹤0.01% | 1889 |
|
2024
Q3 | $10.7K | Sell |
575
-87
| -13% | -$1.62K | ﹤0.01% | 1803 |
|
2024
Q2 | $11K | Buy |
662
+1
| +0.2% | +$17 | ﹤0.01% | 1769 |
|
2024
Q1 | $11.5K | Buy |
661
+576
| +678% | +$10K | ﹤0.01% | 1766 |
|
2023
Q4 | $1.34K | Buy |
+85
| New | +$1.34K | ﹤0.01% | 1956 |
|
2022
Q3 | – | Sell |
-6
| Closed | -$1K | – | 2258 |
|
2022
Q2 | $1K | Sell |
6
-5,532
| -100% | -$922K | ﹤0.01% | 2100 |
|
2022
Q1 | $860K | Buy |
+5,538
| New | +$860K | ﹤0.01% | 1298 |
|